No tariffs on anti-cancer medicines to China from May
Share - WeChat
Starting May 1, China will levy no tariffs on imports of anti-cancer medicines, the State Council said on Thursday.
The State Council released this news at its executive meeting on April 12, chaired by Premier Li Keqiang.
The meeting decided to develop the Internet plus Medical and Healthcare strategy to let Chinese citizens get better access to medical treatments and improve their health.
Premier Li Keqiang visited Shanghai Roche Pharmaceuticals, which focuses on anti-cancer medicines, on Tuesday. He said: "We welcome foreign companies to invest in China and will further open up. Opening-up is a policy that boosts national development and benefits the people."
Related Stories
- Chinese biotech firm Beroni partners Aussie university to trial anti-cancer molecule
- Changes to daily life from 'two sessions' policies
- Li says further opening-up of economy to benefit everyone
- 10 springtime foods to indulge your palate
- Roche receives FDA approval for complementary PD-L1 (SP263) biomarker test
- China's Global Governance Initiative receives positive feedback at forum
- China's Xizang sees steady tourism growth in 2025
- First-of-its-kind pearl auction held utilizing Hainan FTP
- Agarwood exhibition steeps Shanghai museum in fragrance
- The Fujian Coast Guard conducts regular law enforcement patrol in the waters near Jinmen
- IP protection for new fields to improve
































